-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Strategic collaboration, ushering in a new chapter! The successful strategic partnership meeting between Renhe Tang and Linuo Pharmaceutical has just concluded!
Publish Time:
2024-12-12
Against the backdrop of China's Healthy China initiative, the pharmaceutical and healthcare industry is poised to embrace unprecedented growth opportunities—yet it also faces increasingly fierce market competition and mounting pressure to transform and upgrade. To tackle these challenges, strategic collaboration, resource sharing, and mutual complementation of strengths are key for companies to rise to the occasion and seize the emerging opportunities.
On December 12, the strategic cooperation kickoff meeting between Renhe Tang and Linuo Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), was successfully held. Senior leaders and core teams from both companies gathered to engage in in-depth discussions and exchanges across multiple dimensions, including product line optimization, market expansion, and marketing strategies. This collaboration underscores the strong expertise and forward-thinking vision that both parties bring to the pharmaceutical industry, while also injecting powerful momentum into their shared journey toward high-quality, sustainable growth in the future.
Against the backdrop of China's Healthy China initiative, the pharmaceutical and healthcare industry is poised to embrace unprecedented growth opportunities—yet it also faces increasingly fierce market competition and mounting pressure to transform and upgrade. To tackle these challenges, strategic collaboration, resource sharing, and mutual complementation of strengths are key for companies to rise to the occasion and seize the emerging opportunities.
Linuo Pharmaceutical is renowned for its advanced manufacturing processes, rigorous quality-control systems, and extensive product lines. Meanwhile, Renhetang is a time-honored brand with a history spanning over a century, boasting a robust network of stores that stretch across bustling city streets, cozy neighborhood corners, and even remote rural towns. Additionally, its convenient and efficient online pharmacy platform has earned the company a stellar reputation within the industry.
The convening of this strategic alignment meeting has created a golden opportunity for deepened cooperation between the two parties. Moving forward, Renhe Tang will leverage its robust retail channels to open up broader market opportunities for Linuo Pharmaceutical's products, while Linuo Pharmaceutical will fully capitalize on its large-scale production capabilities to supply Renhe Tang with high-quality pharmaceutical offerings, ultimately enabling us to deliver more comprehensive and specialized healthcare services to consumers at large.
We firmly believe that, through the joint efforts of both sides, we will surely write an even more brilliant chapter in the vast and promising realm of the pharmaceutical and healthcare industry, contributing greater strength to the cause of human health.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline